Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Mikami (2014)
Role of lymphadenectomy for ovarian cancerJournal of Gynecologic Oncology, 25
P. Harter, K. Gnauert, R. Hils, T. Lehmann, Annette Fisseler-Eckhoff, A. Traut, A. Bois (2006)
Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancerInternational Journal of Gynecologic Cancer, 17
Juan Zhou, Zhen-Yu He, Feng-Yan Li, Jia-yuan Sun, Huan-xin Lin, San-Gang Wu, Qionghua Chen (2016)
Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based studyOncotarget, 7
C. Bachmann, S. Brucker, B. Krämer, R. Rothmund, A. Staebler, F. Fend, D. Wallwiener, E. Grischke (2015)
RETRACTED ARTICLE: The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancerJournal of Cancer Research and Clinical Oncology, 141
R. Siegel, K. Miller, A. Jemal (2015)
Cancer statistics, 2015CA: A Cancer Journal for Clinicians, 65
T. Anna, M. Signorelli, Pierluigi Benedetti-Panici, Alice Maggioni, Roberta Fossati, Robert Fruscio, Rodolfo Milani, L. Bocciolone, A. Buda, Costantino Mangioni, Giovanni Scambia, R. Angioli, E. Campagnutta, Rosanna Grassi, Fabio Landoni (2012)
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trialBritish Journal of Cancer, 107
M. Melis, A. Masi, A. Pinna, Steven Cohen, Ioannis Hatzaras, R. Berman, Leon Pachter, E. Newman (2015)
Does lymph node ratio affect prognosis in gastroesophageal cancer?American journal of surgery, 210 3
(2015)
Lymph node ratio may predict relapse free survival and overall survival in patients with stage II & III colorectal carcinoma. Hepatogastroenterology
J. Zekri, I. Ahmad, E. Fawzy, T. Elkhodary, Aboelkhair Al-gahmi, A. Hassouna, Mohamed sayed, Jalil Rehman, S. Karim, B. Sadiq (2015)
Lymph node ratio may predict relapse free survival and overall survival in patients with stage II & III colorectal carcinoma.Hepato-gastroenterology, 62 138
K. Eoh, Jung-Yun Lee, J. Yoon, Eun Nam, Sunghoon Kim, Sang-Wun Kim, Young Kim (2016)
Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgeryOncotarget, 8
San-Gang Wu, Zhen-yu He, Qun Li, Jia-yuan Sun, Feng-Yan Li, Q. Lin, Huan-xin Lin, X. Guan (2013)
Prognostic Value of Metastatic Axillary Lymph Node Ratio for Chinese Breast Cancer PatientsPLoS ONE, 8
L. Fischer, M. Katz, S. Lee, Li Liu, Hua Wang, G. Varadhachary, R. Wolff, Jeffrey Lee, A. Maitra, C. Roland, J. Fleming, J. Estrella, A. Rashid, Huamin Wang (2016)
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomyHistopathology, 68
A. Maggioni, P. Panici, T. Dell'anna, F. Landoni, A. Lissoni, A. Pellegrino, R. Rossi, S. Chiari, E. Campagnutta, S. Greggi, R. Angioli, N. Manci, M. Calcagno, G. Scambia, R. Fossati, I. Floriani, V. Torri, R. Grassi, C. Mangioni (2006)
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvisBritish Journal of Cancer, 95
P. Panici, A. Maggioni, N. Hacker, F. Landoni, S. Ackermann, E. Campagnutta, K. Tamussino, R. Winter, A. Pellegrino, S. Greggi, R. Angioli, N. Manci, G. Scambia, T. Dell'anna, R. Fossati, I. Floriani, R. Rossi, R. Grassi, G. Favalli, F. Raspagliesi, D. Giannarelli, L. Martella, C. Mangioni (2005)
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.Journal of the National Cancer Institute, 97 8
B. Ataseven, C. Grimm, P. Harter, S. Prader, A. Traut, F. Heitz, A. Bois (2014)
Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.Gynecologic oncology, 135 3
(1945)
Grischke EM (2015) The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer
C. Bachmann, S. Brucker, B. Kraemer, R. Rothmund, A. Staebler, F. Fend, D. Wallwiener, E. Grischke (2015)
The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer
P. Morice, F. Joulie, S. Camatte, D. Atallah, R. Rouzier, P. Pautier, C. Pomel, C. Lhommé, P. Duvillard, D. Castaigne (2003)
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.Journal of the American College of Surgeons, 197 2
(2010)
Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers
Chen Wei, W. Deng, Ning Li, W. Shen, Chi Zhang, Jia-yu Liu, S. Luo (2015)
Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient SurvivalDigestive Diseases and Sciences, 60
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
A. Bois, A. Reuss, P. Harter, E. Pujade-Lauraine, I. Ray-Coquard, J. Pfisterer (2010)
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 10
The main surgical treatment of stage II and III epithelial ovarian cancer (EOC) is complete cytoreduction, while the main role of lymph node sampling is to exclude microscopic stage III disease in an apparent stage I EOC. This study aims to evaluate the impact of lymph node sampling in stage II and III EOC patients with clinically negative lymph nodes. This is a retrospective cohort study including 51 stage II and III EOC patients treated and followed up between 2012 and 2016. They were treated by complete cytoreduction. Sixteen cases had lymph node sampling, while it was not done in 35 cases. The study was performed at National Cancer Institute (NCI)-Cairo University. There was no statistically significant difference regarding overall survival (P value 0.649) or disease-free survival (P value 0.372) between the group of patients who had lymph node sampling and the other group of patients who had no lymph node sampling. Lymph node ratio (LNR) was not associated with a statistically significant impact regarding overall survival or disease-free survival. There is no impact of lymph node sampling on stage II and III EOC patients with clinically negative lymph nodes.
"Indian Journal of Surgical Oncology" – Springer Journals
Published: Jun 2, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.